Zogenix Inc (ZGNX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5959 HORTON STREET, SUITE 500 EMERYVILLE, CA 94608

Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.

Data based on most recent fiscal year report
Market Cap1.31 Billion Shares Outstanding34.25 Million Avg Volume1.018 Million
1-Yr BETA vs S&P TR1.112 Current Ratio14.52 Quick Ratio14.52
View SEC Filings from ZGNX instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ZGNX now:
Filers who had this stock in their top 10: 10 7 (0.72%)
13F Filers holding this stock: 149 35 (3.62%)
Aggregate 13F shares on 06/30/2019: 51.669 Million 22.421 Million
Aggregate 13F shares on 03/31/2019: 49.551 Million 20.145 Million
Percent change: 4.28% 11.30%
Funds creating new positions: 24 8
Funds Adding to an existing position: 52 9
Funds closing out their position: 39 12
Funds reducing their position: 45 11
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ZGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.4 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
10,802,467 2019-10-16 0

BREITMEYER JAMES B CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-09-12 1

FARR STEPHEN J PRESIDENT AND CEO

  • Officer
  • Director
56,527 2019-08-29 5

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
4,891 2019-08-22 3

BLAIR JAMES C

  • Director
63,544 2019-08-16 0

WIGGINS MARK C

  • Director
0 2019-08-09 2

SMITH MICHAEL P EVP, CFO, TREASURER & SEC.

  • Officer
1,387 2019-08-09 4

KAMDAR KIM P.

  • Director
27,148 2019-08-06 0

SAGROLIKAR ASHISH M EVP & CHIEF COMMERCIAL OFFICER

  • Officer
3,058 2019-07-02 2

HALAK BRIAN K

  • Director
0 2019-06-19 0

HAWLEY ROGER

  • Director
0 2019-06-13 5

TREU JESSE I

  • Director
0 2019-06-04 0

VITULLO NICOLE

  • Director
13,286 2019-05-29 0

BOCK LOUIS C

  • Director
0 2019-05-22 1

MAST ERLE T

  • Director
0 2019-05-22 2

GARNER CAM L

  • Director
0 2019-05-22 4

TANNENBAUM RENEE P

  • Director
0 2019-05-22 2

RHOADS ANN D

  • Director
0 2019-05-02 0

GALER BRADLEY S. EVP/CHIEF MEDICAL OFFICER

  • Officer
0 2019-03-22 2

WHEELER KURT

  • Director
0 2019-01-22 0

MINOCHERHOMJEE ARDA PHD

  • Director
0 2018-08-13 0

DOVEY BRIAN H

  • Director
3,722,188 2018-06-29 0

DARCIS THIERRY J.P. EVP / GENERAL MANAGER, EUROPE

  • Officer
0 2017-03-14 0

SHIVELY RICHARD SCOTT SVP & CHIEF COMMERCIAL OFFICER

  • Officer
4,290 2016-04-02 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
No longer subject to file 2014-03-19 0

DP VII ASSOCIATES LP

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN PARTERS VII L P

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN ASSOCIATES

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
No longer subject to file 2014-03-19 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
No longer subject to file 2014-03-19 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I MANAGEMENT, L.P.

CLARUS VENTURES I, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
  • GENERAL PARTNERGP CLARUS VENTURES I MNGMT.MANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GP
No longer subject to file 2013-09-03 0

ROBINSON CYNTHIA Y CHIEF DEVELOPMENT OFFICER

  • Officer
0 2013-03-15 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
No longer subject to file 2011-09-21 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I, LLC

CLARUS VENTURES I MANAGEMENT, L.P.

LIPTAK ROBERT

SIMON NICHOLAS

HENNER DENNIS

GALAKATOS NICHOLAS

STEINMETZ MICHAEL

  • 10% Owner
5,982,439 2010-11-29 0

THOMAS MCNERNEY & PARTNERS LP

THOMAS, MCNERNEY & PARTNERS, LLC

TMP NOMINEE, LLC

TMP ASSOCIATES LP

THOMAS, MCNERNEY & PARTNERS II L.P.

THOMAS, MCNERNEY & PARTNERS II, LLC

TMP NOMINEE II, LLC

TMP ASSOCIATES II LP

THOMAS JAMES E

MCNERNEY PETE

  • SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)
No longer subject to file 2010-11-29 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

BROOKS MARK J

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • 10% Owner
4,071,546 2010-11-29 0

HAAS KEN

  • Director
2,335,218 2010-11-29 0

CHICAGO GROWTH PARTNERS II L P

CHICAGO GROWTH MANAGEMENT II, LLC

CHICAGO GROWTH MANAGEMENT II, LP

  • SEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2010-11-29 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FARR STEPHEN J - Director - Officer PRESIDENT AND CEO

2019-08-29 F 3,631 $43.82 d 56,527 56,527.00 direct

FARR STEPHEN J - Director - Officer PRESIDENT AND CEO

2019-08-29 M 5,000 $20.00 a 60,158 56,527.00 direct

FARR STEPHEN J - Director - Officer PRESIDENT AND CEO

2019-08-29 M 5,000 d 0 56,527.00 direct

FARFEL GAIL M - Officer EVP/CHIEF DEVELOPMENT OFFICER

2019-08-22 S 3,446 $52.00 d 4,891 4,891.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments